These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39261905)

  • 1. Decreased plasma gelsolin fosters a fibrotic tumor microenvironment and promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma.
    Hsieh CH; Ho PS; Wang WL; Shih FH; Hong CT; Wang PW; Shieh DB; Chang WL; Wang YC
    J Biomed Sci; 2024 Sep; 31(1):90. PubMed ID: 39261905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance.
    Onuma T; Asare-Werehene M; Yoshida Y; Tsang BK
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistance.
    Manzoor HB; Asare-Werehene M; Pereira SD; Satyamoorthy K; Tsang BK
    J Ovarian Res; 2024 Jan; 17(1):15. PubMed ID: 38216951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer.
    Onuma T; Asare-Werehene M; Fujita Y; Yoshida Y; Tsang BK
    Cells; 2024 May; 13(11):. PubMed ID: 38891037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
    Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
    J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
    Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
    Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
    Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
    Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages.
    Sakamoto H; Koma YI; Higashino N; Kodama T; Tanigawa K; Shimizu M; Fujikawa M; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2021 Mar; 101(3):353-368. PubMed ID: 33311557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY; Yeo SY; Xuan YH; Kim SH
    PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
    Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
    Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
    Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of plasma gelsolin in tumorigenesis and modulating the tumor microenvironment.
    Hsieh CH; Wang YC
    Kaohsiung J Med Sci; 2022 Sep; 38(9):819-825. PubMed ID: 35942641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 17. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.
    Kuo IY; Huang YL; Lin CY; Lin CH; Chang WL; Lai WW; Wang YC
    J Biomed Sci; 2019 Feb; 26(1):20. PubMed ID: 30777052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression.
    Chen J; Yang H; Wen J; Luo K; Liu Q; Huang Y; Zheng Y; Tan Z; Huang Q; Fu J
    Oncotarget; 2015 May; 6(14):12405-20. PubMed ID: 25915159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.